Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

12 Health Care Stocks Moving In Thursday's Intraday Session

Author: Benzinga Insights | July 31, 2025 01:08pm

Gainers

  • Soligenix (NASDAQ:SNGX) shares rose 192.0% to $3.65 during Thursday's regular session. The market value of their outstanding shares is at $4.0 million.
  • InspireMD (NASDAQ:NSPR) stock rose 22.13% to $2.89. The market value of their outstanding shares is at $72.6 million.
  • Onconetix (NASDAQ:ONCO) shares increased by 21.73% to $3.91. The market value of their outstanding shares is at $1.6 million.
  • SNDL (NASDAQ:SNDL) shares increased by 21.18% to $1.75. The company's market cap stands at $370.5 million. As per the press release, Q2 earnings came out today.
  • Plus Therapeutics (NASDAQ:PSTV) shares moved upwards by 18.6% to $0.54. The market value of their outstanding shares is at $23.3 million.
  • Jyong Biotech (NASDAQ:MENS) shares increased by 18.56% to $21.3. The company's market cap stands at $1.3 billion.

Losers

  • Pulmonx (NASDAQ:LUNG) shares declined by 39.7% to $1.9 during Thursday's regular session. The company's market cap stands at $125.3 million. The company's, Q2 earnings came out yesterday.
  • GRI Bio (NASDAQ:GRI) stock fell 37.35% to $1.28. The market value of their outstanding shares is at $5.1 million.
  • Ontrak (NASDAQ:OTRK) shares decreased by 36.5% to $0.31. The company's market cap stands at $3.4 million.
  • Align Technology (NASDAQ:ALGN) shares declined by 35.12% to $132.09. The company's market cap stands at $14.7 billion. The company's, Q2 earnings came out yesterday.
  • Baxter Intl (NYSE:BAX) shares decreased by 19.12% to $22.69. The company's market cap stands at $14.3 billion. As per the press release, Q2 earnings came out today.
  • Salarius Pharmaceuticals (NASDAQ:SLRX) stock declined by 15.0% to $0.67. The market value of their outstanding shares is at $1.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ALGN BAX GRI LUNG MENS NSPR ONCO OTRK PSTV SLRX SNDL SNGX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist